Since 2018, we have been fully dedicated to satisfying this demand by managing complete clinical trials. To this day, we continue to make a mark by providing safe and reliable clinical trial solutions with PAN India coverage.
Expert guidance at each step for your product launch along with hassle free regulatory approvals
Our customized services are designed to address your specific needs and deliver a smooth development pathway for your product launch
Focusing on high-quality clinical trial management services, we aim to be your one stop CRO
Leadership team that combines expertise with passion
Dr Ashwini founded CliniExperts in 2009 to actualize his ambitious vision for clinical research in India. His knowledge and leadership skills have resulted in over 5,000 approval for leading pharmaceutical companies.
Rashmi holds a B.Tech in Computer Science and has considerable experience working in Big Data analytics and software development. Her passion for state-of-the-art technology is complemented by her expertise across project management, strategy execution, and regulatory compliance.
Ms. Thanuja is an experienced professional in pharmaceutical services and global clinical development for over 30 years with a strong track record of growth, leadership, and overseeing global delivery programs. Successfully set up centralized departments across various functional verticals and won new businesses in APAC region. Proficient in clinical operations, drug development, regulatory authorization, and commercialization of pharmaceuticals. Skilled in working with global and regional stakeholders in multiple therapeutic areas, and delivering exceptional results with a commitment to quality, productivity, profitability, and people development.
Dr Dimri is a Dermatologist with experience in pharmacovigilance. Her experience spans over 15 years in Asian geographies India, China and Singapore. She began her career as an assistant professor of Dermatology at KMC, Mangalore in 2008, and juggled roles as consultant dermatologist at various reputed institutions. She served as a Consultant Dermatologist at Parkway Healthcare in Shanghai between 2013 and 2019, and then went on to join Lundbeck, Singapore as a Safety Physician - Global Patient Safety.
Dr Dimri describes herself as an industrious, goal-oriented professional who capitalises on agility and ensuring highest level of functionality and productivity.
Periodic safety update reports (PSUR) are pharmacovigilance documents that allow a periodic but comprehensive assessment of the risk-benefit balance of a medicinal product after it is marketed. The main purpose of the PSUR is to identify new or emerging safety information, as a means of determining changes in the benefit-risk profile of the authorised drug.
The New drugs and clinical trials rules, 2019, requires that the investigator, sponsor / CT-NOC holder and ethics committee report all serious adverse events (SAE’s) to the Central Licensing Authority (CLA) within a specified time-frame.
Clinical trials are essential to deliver new therapies and advance medical knowledge and patient care. A key aspect of a successful clinical trial is the efficient management of clinical sites.
Are Investigational New Drug Trials in India A Positive Sign For Healthcare: The Researchers Perspective
